Pulmonary Vein Myocardial Sleeve Length and its Association With Sex and 4q25/PITX2 Genotype

• Published in: JACC. Clinical electrophysiology Vol. 9; no. 7; pp. 1147 - 1157
• Main Authors: El-Harasis, Majd A., Yoneda, Zachary T., Davogustto, Giovanni E., Crawford, Diane M., Laws, James L., Frye, Bradley, Herrmann, Tarrah, Patel, Bindiya, Touchton, Steven A., Roden, Dan M., Richardson, Travis D., Saavedra, Pablo, Shen, Sharon T., Estrada, Juan C., Kanagasundram, Arvindh N., Montgomery, Jay A., Michaud, Gregory F., Crossley, George H., Ellis, Christopher R., Shoemaker, M. Benjamin
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.07.2023
• Subjects: 4q25 genotype; Aged; atrial fibrillation; Atrial Fibrillation - genetics; Atrial Fibrillation - surgery; Female; Genotype; Homeobox Protein PITX2; Humans; Male; Middle Aged; Prospective Studies; pulmonary vein myocardial sleeve; Pulmonary Veins - surgery; Risk Factors; atrial fibrillation; 4q25 genotype; SNP; AF; LA; PV; CMR; IQR; pulmonary vein myocardial sleeve; PITX2; BMI
• ISSN: 2405-500X; 2405-5018
• DOI: 10.1016/j.jacep.2022.12.028

Experimental evidence suggests genetic variation in 4q25/PITX2 modulates pulmonary vein (PV) myocardial sleeve length. Although PV sleeves are the main target of atrial fibrillation (AF) ablation, little is known about the association between different PV sleeve characteristics with ablation outcomes. This study sought to evaluate the association between clinical and genetic (4q25) risk factors with PV sleeve length in humans, and to evaluate the association between PV sleeve length and recurrence after AF ablation. In a prospective, observational study of patients undergoing de novo AF ablation, PV sleeve length was measured using electroanatomic voltage mapping before ablation. The sentinel 4q25 AF susceptibility single nucleotide polymorphism, rs2200733, was genotyped. The primary analysis tested the association between clinical and genetic (4q25) risk factors with PV sleeve length using a multivariable linear regression model. Covariates included age, sex, body mass index, height, and persistent AF. The association between PV sleeve length and atrial arrhythmia recurrence (>30 seconds) was tested using a multivariable Cox proportional hazards model. Between 2014 and 2019, 197 participants were enrolled (median age 63 years [IQR: 55 to 70 years], 133 male [67.5%]). In multivariable modeling, men were found to have PV sleeves 2.94 mm longer than women (95% CI: 0.99-4.90 mm; P < 0.001). Sixty participants (30.5%) had one 4q25 risk allele and 6 (3.1%) had 2 alleles. There was no association between 4q25 genotype and PV sleeve length. Forty-six participants (23.4%) experienced arrhythmia recurrence within 3 to 12 months, but there was no association between recurrence and PV sleeve length. Common genetic variation at 4q25 was not associated with PV sleeve length and PV sleeve length was not associated with ablation outcomes. Men did have longer PV sleeves than women, but more research is needed to define the potential clinical significance of this observation. [Display omitted]